Literature DB >> 18845784

Resistance exercise increases human skeletal muscle AS160/TBC1D4 phosphorylation in association with enhanced leg glucose uptake during postexercise recovery.

Hans C Dreyer1, Micah J Drummond, Erin L Glynn, Satoshi Fujita, David L Chinkes, Elena Volpi, Blake B Rasmussen.   

Abstract

Akt substrate of 160 kDa (AS160/TBC1D4) is associated with insulin and contraction-mediated glucose uptake. Human skeletal muscle AS160 phosphorylation is increased during aerobic exercise but not immediately following resistance exercise. It is not known whether AS160 phosphorylation is altered during recovery from resistance exercise. Therefore, we hypothesized that muscle AS160/TBC1D4 phosphorylation and glucose uptake across the leg would be increased during recovery following resistance exercise. We studied 9 male subjects before, during, and for 2 h of postexercise recovery. We utilized femoral catheterizations and muscle biopsies in combination with indirect calorimetry and immunoblotting to determine whole body glucose and fat oxidation, leg glucose uptake, muscle AMPKalpha2 activity, and the phosphorylation of muscle Akt and AS160/TBC1D4. Glucose oxidation was reduced while fat oxidation increased ( approximately 35%) during postexercise recovery (P <or= 0.05). Glucose uptake increased during exercise and postexercise recovery (P <or= 0.05). Akt phosphorylation was increased at 1 h and AMPKalpha2 activity increased at 2 h postexercise (P <or= 0.05). Phospho(Ser/Thr)-Akt substrate (PAS) phosphorylation (often used as a marker for AS160) was unchanged immediately postexercise and increased at 1 h (P <or= 0.05) and 2 h postexercise (P = 0.07). The PAS antibody is not always specific for AS160/TBC1D4 and can detect proteins at a similar molecular weight. Therefore, we immunoprecipitated AS160/TBC1D4 and then blotted with the PAS antibody, which confirmed that PAS phosphorylation is occurring on AS160/TBC1D4. There was also a positive correlation between PAS phosphorylation and leg glucose uptake during recovery (P < 0.05). We conclude that resistance exercise increases AS160/TBC1D4 phosphorylation in association with an increase in leg glucose uptake during postexercise recovery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845784      PMCID: PMC2612462          DOI: 10.1152/japplphysiol.90562.2008

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  34 in total

Review 1.  Contraction signaling to glucose transport in skeletal muscle.

Authors:  Niels Jessen; Laurie J Goodyear
Journal:  J Appl Physiol (1985)       Date:  2005-07

2.  Exercise-induced phosphorylation of the novel Akt substrates AS160 and filamin A in human skeletal muscle.

Authors:  Atul Deshmukh; Vernon G Coffey; Zhihui Zhong; Alexander V Chibalin; John A Hawley; Juleen R Zierath
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

3.  Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle.

Authors:  Hans C Dreyer; Satoshi Fujita; Jerson G Cadenas; David L Chinkes; Elena Volpi; Blake B Rasmussen
Journal:  J Physiol       Date:  2006-07-27       Impact factor: 5.182

4.  Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle.

Authors:  Henning F Kramer; Carol A Witczak; Nobuharu Fujii; Niels Jessen; Eric B Taylor; David E Arnolds; Kei Sakamoto; Michael F Hirshman; Laurie J Goodyear
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

5.  AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits.

Authors:  Jonas T Treebak; Stephan Glund; Atul Deshmukh; Ditte K Klein; Yun Chau Long; Thomas E Jensen; Sebastian B Jørgensen; Benoit Viollet; Leif Andersson; Dietbert Neumann; Theo Wallimann; Erik A Richter; Alexander V Chibalin; Juleen R Zierath; Jørgen F P Wojtaszewski
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

6.  Insulin signaling and glucose transport in skeletal muscle from first-degree relatives of type 2 diabetic patients.

Authors:  Håkan K R Karlsson; Maria Ahlsén; Juleen R Zierath; Harriet Wallberg-Henriksson; Heikki A Koistinen
Journal:  Diabetes       Date:  2006-05       Impact factor: 9.461

7.  IRS-1 serine phosphorylation and insulin resistance in skeletal muscle from pancreas transplant recipients.

Authors:  Karim Bouzakri; Håkan K R Karlsson; Henrik Vestergaard; Sten Madsbad; Erik Christiansen; Juleen R Zierath
Journal:  Diabetes       Date:  2006-03       Impact factor: 9.461

Review 8.  AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes.

Authors:  W W Winder; D G Hardie
Journal:  Am J Physiol       Date:  1999-07

9.  Exercise-induced alterations in extracellular signal-regulated kinase 1/2 and mammalian target of rapamycin (mTOR) signalling to regulatory mechanisms of mRNA translation in mouse muscle.

Authors:  David L Williamson; Neil Kubica; Scot R Kimball; Leonard S Jefferson
Journal:  J Physiol       Date:  2006-03-16       Impact factor: 5.182

10.  Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study.

Authors:  Apiradee Sriwijitkamol; Dawn K Coletta; Estela Wajcberg; Gabriela B Balbontin; Sara M Reyna; John Barrientes; Phyllis A Eagan; Christopher P Jenkinson; Eugenio Cersosimo; Ralph A DeFronzo; Kei Sakamoto; Nicolas Musi
Journal:  Diabetes       Date:  2007-03       Impact factor: 9.461

View more
  14 in total

1.  Acute high-fat feeding does not prevent the improvement in glucose tolerance after resistance exercise in lean individuals.

Authors:  Christopher S Shaw; Natalie M Cooper; Oliver Shaw; Paulo Salomao; Anton J M Wagenmakers
Journal:  Eur J Appl Physiol       Date:  2011-03-05       Impact factor: 3.078

2.  Safety and Efficacy of Mobility Interventions in Patients with Femoral Catheters in the ICU: A Prospective Observational Study.

Authors:  Christiane Perme; Theresa Nalty; Chris Winkelman; Ricardo Kenji Nawa; Faisal Masud
Journal:  Cardiopulm Phys Ther J       Date:  2013-06

Review 3.  AMP-activated protein kinase and metabolic control.

Authors:  Benoit Viollet; Fabrizio Andreelli
Journal:  Handb Exp Pharmacol       Date:  2011

4.  Naturally occurring compensated insulin resistance selectively alters glucose transporters in visceral and subcutaneous adipose tissues without change in AS160 activation.

Authors:  A P Waller; K Kohler; T A Burns; M C Mudge; J K Belknap; V A Lacombe
Journal:  Biochim Biophys Acta       Date:  2011-02-23

5.  Exercise type and volume alter signaling pathways regulating skeletal muscle glucose uptake and protein synthesis.

Authors:  Juha P Ahtiainen; Simon Walker; Mika Silvennoinen; Heikki Kyröläinen; Bradley C Nindl; Keijo Häkkinen; Kai Nyman; Harri Selänne; Juha J Hulmi
Journal:  Eur J Appl Physiol       Date:  2015-04-10       Impact factor: 3.078

Review 6.  Exercise and insulin: Convergence or divergence at AS160 and TBC1D1?

Authors:  Gregory D Cartee; Katsuhiko Funai
Journal:  Exerc Sport Sci Rev       Date:  2009-10       Impact factor: 6.230

7.  Increased AS160 phosphorylation, but not TBC1D1 phosphorylation, with increased postexercise insulin sensitivity in rat skeletal muscle.

Authors:  Katsuhiko Funai; George G Schweitzer; Naveen Sharma; Makoto Kanzaki; Gregory D Cartee
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-12       Impact factor: 4.310

Review 8.  Roles of TBC1D1 and TBC1D4 in insulin- and exercise-stimulated glucose transport of skeletal muscle.

Authors:  Gregory D Cartee
Journal:  Diabetologia       Date:  2014-10-04       Impact factor: 10.122

9.  Potential role of TBC1D4 in enhanced post-exercise insulin action in human skeletal muscle.

Authors:  J T Treebak; C Frøsig; C Pehmøller; S Chen; S J Maarbjerg; N Brandt; C MacKintosh; J R Zierath; D G Hardie; B Kiens; E A Richter; H Pilegaard; J F P Wojtaszewski
Journal:  Diabetologia       Date:  2009-02-28       Impact factor: 10.122

Review 10.  Targeting the AMPK pathway for the treatment of Type 2 diabetes.

Authors:  Benoit Viollet; Louise Lantier; Jocelyne Devin-Leclerc; Sophie Hebrard; Chloe Amouyal; Remi Mounier; Marc Foretz; Fabrizio Andreelli
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.